Chinese state-owned drugmaker Shanghai Pharmaceuticals said on Wednesday it had agreed to pay for $557m for Cardinal Health Inc’s China business, one of the country’s largest drug distributors. Shanghai Pharmaceuticals said in a statement that the …
( read original story …)